Avricore Health (AVCRF) Return on Capital Employed (2012 - 2025)

Avricore Health (AVCRF) has reported Return on Capital Employed for 14 consecutive years, with 177.8% the latest figure, recorded in Q4 2025.

• In Q4 2025, Return on Capital Employed changed N/A year-over-year to 177.8%; the TTM figure through Dec 2025 stood at 177.8% (changed N/A YoY), while the FY2025 annual figure was 108.01%, down 11407.0% from the prior year.
• Return on Capital Employed declined to 177.8% in Q4 2025 per AVCRF's latest filing, from 75.66% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 11.64% in Q3 2024 and bottomed at 177.8% in Q4 2025.
• Historically, Return on Capital Employed has averaged 27.26% across 5 years, with a median of 17.27% in 2022.
• Annual changes were most pronounced in 2021 — Return on Capital Employed tumbled 15318 bps — and 2024, when it surged 5397 bps.
• Avricore Health's Return on Capital Employed stood at 8.16% in 2021, then tumbled by 373 bps to 38.57% in 2022, then jumped by 48 bps to 20.2% in 2023, then jumped by 158 bps to 11.64% in 2024, then slumped by 1627 bps to 177.8% in 2025.
• Business Quant data shows AVCRF's Return on Capital Employed at 177.8% in Q4 2025, 75.66% in Q3 2025, and 27.95% in Q2 2025.